Geode Capital Management
UNCY icon

Geode Capital Management’s Unicycive Therapeutics UNCY Stock Holding History

Geode Capital Management’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65M Buy
564,019
+360,275
+177% +$2.66M ﹤0.01% 3130
2026
Q1 		$1.34M Buy
203,744
+32,454
+19% +$213K ﹤0.01% 3266
2025
Q4 		$989K Buy
171,290
+45,563
+36% +$243K ﹤0.01% 3381
2025
Q3 		$548K Buy
125,727
+66,941
+114% +$292K ﹤0.01% 3584
2025
Q2 		$280K Buy
58,786
+866
+1% +$5.36K ﹤0.01% 3763
2025
Q1 		$333K Buy
57,920
+5,471
+10% +$33.4K ﹤0.01% 3685
2024
Q4 		$417K Buy
52,449
+12,209
+30% +$67.6K ﹤0.01% 3668
2024
Q3 		$164K Buy
40,240
+11,666
+41% +$46.8K ﹤0.01% 3967
2024
Q2 		$143K Buy
28,574
+3,255
+13% +$32K ﹤0.01% 4026
2024
Q1 		$349K Buy
25,319
+8,406
+50% +$102K ﹤0.01% 3742
2023
Q4 		$147K Buy
16,913
+11,673
+223% +$76.3K ﹤0.01% 4051
2023
Q3 		$45.1K Sell
5,240
-1,435
-21% -$13.4K ﹤0.01% 4443
2023
Q2 		$85.4K Sell
6,675
-2,915
-30% -$45.5K ﹤0.01% 4386
2023
Q1 		$201K Buy
9,590
+6,979
+267% +$69.5K ﹤0.01% 4048
2022
Q4 		$13K Hold
2,611
– – ﹤0.01% 4821
2022
Q3 		$15K Hold
2,611
– – ﹤0.01% 4948
2022
Q2 		$21K Hold
2,611
– – ﹤0.01% 4917
2022
Q1 		$33K Hold
2,611
– – ﹤0.01% 4887
2021
Q4 		$53K Hold
2,611
– – ﹤0.01% 4851
2021
Q3 		$73K Buy
+2,611
New +$74.9K ﹤0.01% 4728

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.94% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Geode Capital Management's UNCY Position: Q2 2026 in Review

Geode Capital Management increased its Unicycive Therapeutics (UNCY) stake by 177% in Q2 2026, buying an estimated $2.66M and bringing the position to 564,019 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

Geode Capital Management first reported a position in UNCY in Q3 2021 and has held it in 20 quarters since. 73 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Geode Capital Management held 564,019 shares of Unicycive Therapeutics worth $2.65M as of Q2 2026.
  • Geode Capital Management bought 360,275 Unicycive Therapeutics shares in Q2 2026, an estimated $2.66M.
  • Unicycive Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3130 holding.
  • Geode Capital Management first reported a position in Unicycive Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 73 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.